Exonhit presents new opportunities in blood diagnostics in neurodegenerative diseases
Identification of new markers for BSE in collaboration with Roche Applied Science
ExonHit Therapeutics announced that the company has identified new blood markers in collaboration with Roche Applied Science for the detection of bovine spongiform encephalopathy (BSE) in living animals. The development of a blood-based BSE test would herald a new era by diagnosing BSE-infected animals prior to death and before they enter the food chain. Today, the routine testing of BSE is still performed using immunological tests to detect the protease-resistant form of the prion protein in brain samples of dead animals.
ExonHit applied its DATAS® RNA profiling technology on blood samples from bovines provided by Roche Applied Science and has identified early pre-symptomatic disease markers. The resulting RNA splicing markers were validated with 10 individual whole blood samples of BSE-infected cattle and 10 individual whole blood samples of healthy control animals by two technologically different means: micro array analysis at ExonHit and real-time PCR at Roche with the Roche LightCycler Instrument. Both validation setups revealed the same set of three markers that clearly discriminate between BSE-infected and healthy individuals. ExonHit retains all IP rights on the markers identified and diagnostics use.
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
See the theme worlds for related content
Last viewed contents

Intuition and failure as valuable ingredients in chemical research - Methodology to collect lessons learned from partially failed trials and incorrect hypotheses

DNA repair: Opening the hatch to heal the break
ATP as trigger for targeted anti-cancer drug delivery
Society for Neuroscience - Washington, USA
Pronova BioPharma's PRC-4016 to begin clinical trials for mixed dyslipidemia
Novozymes and Prometic enter into alliance for purification of albumin-fusion proteins

Salmonella Detection - Simple Colorimetric Sensor Rapidly Detects Food Contamination Using a Nucleic Acid Probe
Eisai Opens Regional Office in Bahrain
Pfizer Acquires Antibody Discovery and Optimization Company

Discovery of a potential new therapy for inflammatory arthritis - Researchers at the Schroeder Arthritis Institute in Toronto have made a discovery that could lead to new treatments for axial spondyloarthritis.

Lung organoids unveil secret: How pathogens infect human lung tissue - New sensor for monitoring bacteria
